Skip to content

Perceived Barriers of Cervical Cancer Screening in Reunion Island and Key Levers for Improvment

Identification Des barrières au dépistage du Cancer du Col utérin à la Réunion et Des Leviers d'amélioration

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02907970
Acronym
FOSFORE
Enrollment
1000
Registered
2016-09-20
Start date
2017-02-20
Completion date
2017-06-30
Last updated
2018-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Cervical Neoplasms

Keywords

Cervical cancer, Screening, Barriers

Brief summary

FOSFORE study aims at identifying the barriers of cervical cancer screening in Reunion Island and key levers for improvment.

Detailed description

FOSFORE is a cross sectional KABP (Knowledge, Attitudes, Beliefs and Practices) telephone survey on cervical cancer screening from a sounding board of women aged between 25 and 65 years and living in Reunion Island. Sample size was estimated from local datas on cervical cancer screening.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de la Réunion
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Women aged between 25 and 65 yo * living in Reunion Island * speaking French, Creole or Shimaore language * able to answer phone

Exclusion criteria

* history of hysterectomy * history of incomplete or total conisation

Design outcomes

Primary

MeasureTime frameDescription
Type of barriers in cervical cancer screening6 monthsTelephone survey with a KABP-like questionnaire
Proportion of barriers in cervical cancer screening6 monthsTelephone survey with a KABP-like questionnaire

Secondary

MeasureTime frameDescription
Type of levers in cervical cancer screening6 monthsTelephone survey with a KABP-like questionnaire
Proportion of levers in cervical cancer screening6 monthsTelephone survey with a KABP-like questionnaire

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026